Evidence map›Paper›PMID 32817301›Full record

ArticleLearning & memory (Cold Spring Harbor, N.Y.)2020

Evaluation of a TrkB agonist on spatial and motor learning in the

Maria N Schultz, Jacqueline N Crawley

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Learning & memory (Cold Spring Harbor, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria N SchultzMIND Institute, Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California 95821, USA.
Jacqueline N CrawleyMIND Institute, Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California 95821, USA.
University of California, Davis · US

Funding

Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI VAN DE WATER, JUDY A. · 2013 to 2019
$8.5M
Convergent Synaptic Mechanisms in Neurodevelopmental DisordersR01NS085709 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CRAWLEY, JACQUELINE N, GALL, CHRISTINE M · 2013 to 2017
$2.8M
NICHD NIH HHS U54 HD079125NINDS NIH HHS R01 NS085709
6 · The paper itself

Abstract

Angelman syndrome is a rare neurodevelopmental disorder caused by a mutation in the maternal allele of the gene

Indexed as

Age FactorsAngelman SyndromeAnimalsBehavior, AnimalDisease Models, AnimalFemaleFlavonesMaleMaze LearningMembrane GlycoproteinsMiceMice, KnockoutMotor ActivityPhenotypeProtein-Tyrosine KinasesReceptor, trkB6,7-dihydroxyflavoneFlavonesMembrane GlycoproteinsNtrk2 protein, mouseProtein-Tyrosine KinasesReceptor, trkBUbe3a protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID32817301
PMCPMC7433657
OpenAlexW3074267315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.